Browse studies

Find your next paid study

27,354 recruiting studies available now

The Pharmacokinetics of a Hemp-Based Topical Cannabinoid Product in a Sanitized and Controlled Environment

This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-te…

Cannabis

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Johns Hopkins UniversityNCT07603518

Phase 1

A PHASE 1, OPEN-LABEL, SINGLE-DOSE, PARALLEL-COHORT STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PF-07328948 IN ADULTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIRMENT

The purpose of this study is to understand the effects of decreased liver function on the study medicine (PF-07328948). People with decreased liver function ma…

Hepatic ImpairmentHealthy

Estimated

~$500 – $11,250

Actual pay is set by the research site.

PfizerNCT07269301

Phase 1

A First-in-human Phase I, Open-label, Multicentre, Dose Escalation Trial of BI 3819026 in Combination With Ezabenlimab in Patients With Unresectable Advanced or Metastatic Solid Cancers to Determine the Maximum Tolerated Dose (MTD) and Recommended Dose for Expansion (RDE)

This study is open to adults with advanced cancer. The purpose of this study is to find the highest dose of BI 3819026 that people with advanced cancer can tol…

Advanced Solid CancerMetastatic Solid Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Boehringer IngelheimNCT07607678

Phase 1

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

To learn about the safety and effects of revumenib in combination with blinatumomab in patients with newly diagnosed or relapsed/refractory Ph-negative ALL wit…

BlinatumomabRevumenibLymphoblastic Leukemia+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07283640

Phase 2

A Randomized Double-Blind Trial of Abatacept Extended Dosing Versus Abatacept Short-term Dosing for Graft Versus Host Disease Prophylaxis: "ABA3"

This is a multicenter randomized, double blind, Phase 2 trial for patients receiving transplants from 7 of 8 HLA matched donors, in which an extended dosing re…

Graft Vs Host Disease

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Boston Children's HospitalNCT04380740

Observational

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 2) (IRIS-CKD)

IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with typ…

Chronic Kidney Disease(CKD)Type 2 DMType 2 Diabetes Mellitus (T2DM)

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT06906640

Expanding Access to Cognitive Health Biomarker Testing at Home

The goal of this observational study is to learn whether at-home blood biomarker testing for Alzheimer's disease risk is feasible and acceptable in older adult…

Mild Cognitive Impairment (MCI)Alzheimer's Dementia (AD)Subjective Cognitive Decline (SCD)+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of VirginiaNCT07594665

Observational

A Randomized Trial to Encourage Older Adults and Adults With Serious Illness to Designate a Health Care Proxy

This study is a Stage III randomized trial to encourage patients in advance of a health care appointment to designate a healthcare proxy. Patients will be rand…

Designating a Healthcare Proxy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Southern CaliforniaNCT07290478

Phase 2

Electronic Nose (E-nose) Technology to Assess Pathologic Response and Post- Treatment Progression for Non-small Cell Lung Cancer: a Phase II Study

The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure changes in certain …

Non-Small Cell Lung Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07218601

Phase 1

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis has a poor prognosis with limited treatment options. The Investigator hypothesize hyperpolarized Xe129-MRI can be performed in pa…

Idiopathic Pulmonary Fibrosis

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of VirginiaNCT06853145

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

The goal of this observational study is to learn how two medicines used in routine care-buprenorphine and morphine-affect recovery in newborns (≥36 weeks' gest…

Neonatal Opioid Withdrawal Syndrome

Estimated

~$10 – $1,125

Actual pay is set by the research site.

HELP for NOWS ConsortiumNCT07278375

Observational

Clinical and Neurophysiological Effects of Accelerated rTMS on Sleep Architecture in Chronic Insomnia Disorder: A Prospective Pilot Study

Chronic insomnia disorder is a common condition in which people have ongoing difficulty falling asleep, staying asleep, or waking too early. It affects about 1…

InsomniaChronic InsomniaChronic Insomnia Disorder+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

San Francisco Neurology and Sleep CenterNCT07595185